Cell Death and Survival |
apoptosis of lung cancer cell lines |
5.80E-06 |
↓ |
CAMP, EREG, G0S2, HSPA5, MCL1, RASD1, SERPINF1, TNFSF10 |
apoptosis of tumor cell lines |
2.08E-05 |
↓ |
AR, BCL2A1, CAMP, CAV1, COL18A1, CREM, CTSD, EREG, G0S2, HSPA5, IL18, MAOA, MCL1, NFKBIA, NR0B2, PLAU, RASD1, SERPINF1, TNFSF10, UCHL1 |
cell death of lung cancer cell lines |
3.21E-06 |
↓ |
CAMP, EREG, G0S2, HSPA5, MCL1, NFKBIA, RASD1, SERPINF1, TNFSF10 |
cell death of tumor cell lines |
2.75E-05 |
↓ |
AR, BCL2A1, BTG1, CAMP, CAV1, COL18A1, CREM, CTSD, EREG, FETUB, G0S2, HSPA5, IL18, MAOA, MCL1, NFKBIA, NR0B2, PLAU, PPAT, RASD1, SERP |
cellular degradation |
3.77E-04 |
↓ |
AR, CACNA1D, CAV1, CREM, CTSD, LYZ, UCHL1 |
Cellular Assembly and Organization |
formation of filaments |
1.36E-03 |
↑ |
AR, CAV1, COL18A1, HSPA5, PTGDS, SERPINF1, TTR, TUBB |
Organismal Development |
development of body axis |
1.99E-04 |
↑ |
ANGPTL3, CCKAR, COL18A1, CREM, CTSD, DIO3, GPR34, HHEX, HSP90B1, INSIG1, LUM, MAOA, NFKBIA, PLAU, SERPINF1 |
Immune Cell Trafficking |
activation of antigen presenting cells |
3.47E-04 |
↓ |
CAMP, GJB1, HNF4A, HSP90B1, IL18, LECT2, SERPINF1, TNFSF10 |
Renal and Urological System Development |
cell viability of kidney cell lines |
3.05E-04 |
↓ |
CAV1, HSP90B1, HYOU1, NFKBIA |
Cardiovascular Disease |
vascular lesion |
2.94E-07 |
↑ |
ACAT2, CACNA1D, COL18A1, IL18, LPL, MGP, mir-221, NFKBIA, PLAU, TNFSF10 |